Tybourne Capital Management as of March 31, 2025
Portfolio Holdings for Tybourne Capital Management
Tybourne Capital Management holds 5 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Acelyrin | 30.5 | $7.2M | 2.9M | 2.47 | |
| Taysha Gene Therapies Com Shs (TSHA) | 21.8 | $5.1M | 3.7M | 1.39 | |
| Bicycle Therapeutics Ltd- Sponsored Ads (BCYC) | 20.8 | $4.9M | 576k | 8.49 | |
| Forte Biosciences Com New (FBRX) | 20.4 | $4.8M | 620k | 7.76 | |
| Zentalis Pharmaceuticals (ZNTL) | 6.5 | $1.5M | 962k | 1.59 |
